| name | Butenafine |
| Classification | Antifungal, specifically a topical treatment for onychomycosis (fungal nail infection). |
| Pharmacokinetics | Topical application; butenafine is absorbed poorly through the skin, so systemic effects are minimal. The majority of the drug remains localized to the affected nail bed. Metabolism occurs primarily through the skin. |
| suggested dosage | Usually applied topically once daily to the affected nail and surrounding skin for 6-12 months. Specific instructions are often provided on the product packaging by the prescribing physician. |
| indications | Treatment of onychomycosis (fungal nail infection), particularly caused by dermatophytes. |
| safety in pregnancy | Limited data on use in pregnant women. Generally considered safe when used topically at the prescribed dosage, as systemic absorption is low. Always consult a healthcare provider before use. |
| safety in breastfeeding | Limited data on use in breastfeeding mothers. Generally considered safe when used topically at the prescribed dosage, as systemic absorption is low. Always consult a healthcare provider before use. |
| side effects | | 1 | Skin irritation (e.g., redness, burning, itching, dryness) | | 2 | Rash | | 3 | Nail discoloration (usually temporary) | | 4 | local pain | | 5 | Allergic reactions (rare) |
|
| alternatives | |
| contraindications | | 1 | Known hypersensitivity or allergy to butenafine or other ingredients in the formulation. | | 2 | Severe skin conditions at the application site. |
|
| interactions | Limited clinically significant interactions reported. Butenafine is primarily topical, so interaction with other systemic drugs is rare. However, interaction with other topical treatments applied to the same area may occur, and need to be discussed with physician. |
| warnings and precautions | | 1 | Apply only to the affected area. Avoid contact with eyes. | | 2 | Do not use on open wounds or broken skin. | | 3 | Use only as directed by your healthcare provider. | | 4 | If symptoms worsen or new symptoms develop, stop use and contact your physician. | | 5 | Monitor response to treatment, and discontinue use if not seeing improvement or adverse effects arise. | | 6 | Thorough nail cleaning prior to applying the treatment often necessary to improve efficacy. |
|
| additional informations | The duration of treatment for onychomycosis can be prolonged, often requiring months. Adherence to the treatment regimen is essential for successful treatment. |
| patient profile | | age | 25 years | | weight | 70 kg | | sex | male |
|
